内容へ

整形外科

術前の患者の評価と輸血リスクの評価

Estimating the transfusion risk following total knee arthroplasty. (新しいタブで開く)

Ahmed I, Chan JK, Jenkins P, Brenkel I, Walmsley P.

出典‎: Orthopedics 2012;35(10):e1465-71.

インデックス‎: PubMed 23027481

DOI‎: 10.3928/01477447-20120919-13

https://www.ncbi.nlm.nih.gov/pubmed/23027481 (新しいタブで開く)

Ginkgo biloba: persistent bleeding after total hip arthroplasty caused by herbal self-medication. (新しいタブで開く)

Bebbington A, Kulkarni R, Roberts P.

出典‎: J Arthroplasty 2005;20(1):125-6.

インデックス‎: PubMed 15660071

DOI‎: 10.1016/j.arth.2004.02.031

https://www.ncbi.nlm.nih.gov/pubmed/15660071 (新しいタブで開く)

Factors affecting transfusion requirement after hip fracture: can we reduce the need for blood? (新しいタブで開く)

Desai SJ, Wood KS, Marsh J, Bryant D, Abdo H, Lawendy AR, Sanders DW.

出典‎: Can J Surg 2014;57(5):342-8.

インデックス‎: PubMed 25265109

https://www.ncbi.nlm.nih.gov/pubmed/25265109 (新しいタブで開く)

Multicentre cohort study of red blood cell use for revision hip arthroplasty and factors associated with greater risk of allogeneic blood transfusion. (新しいタブで開く)

Walsh TS, Palmer J, Watson D, Biggin K, Seretny M, Davidson H, Harkness M, Hay A.

出典‎: Br J Anaesth 2012;108(1):63-71.

インデックス‎: PubMed 22037224

DOI‎: 10.1093/bja/aer326

https://www.ncbi.nlm.nih.gov/pubmed/22037224 (新しいタブで開く)